Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MEF2C Antikörper (pSer222)

MEF2C Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN6254109
  • Target Alle MEF2C Antikörper anzeigen
    MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
    Bindungsspezifität
    • 28
    • 27
    • 15
    • 10
    • 10
    • 9
    • 8
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer222
    Reaktivität
    • 169
    • 84
    • 59
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 170
    • 5
    • 1
    Kaninchen
    Klonalität
    • 173
    • 3
    Polyklonal
    Konjugat
    • 79
    • 15
    • 10
    • 10
    • 8
    • 8
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser MEF2C Antikörper ist unkonjugiert
    Applikation
    • 123
    • 89
    • 46
    • 33
    • 18
    • 17
    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Kreuzreaktivität
    Human
    Homologie
    bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
    Aufreinigung
    Antigen Affinity Purified from Pooled Serum
    Immunogen
    Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
    Top Product
    Discover our top product MEF2C Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    100 μL in 10 mM HEPES (  pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
    Lagerung
    -20 °C
  • Brown, Still, Koche, Yim, Takao, Cifani, Reed, Gunasekera, Ficarro, Romanienko, Mark, McCarthy, de Stanchina, Gonen, Seshan, Bhola, ODonnell, Spitzer, Stutzke, Lavallée, Hébert, Krivtsov, Melnick et al.: "MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).

  • Target
    MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
    Andere Bezeichnung
    MEF2C (MEF2C Produkte)
    Synonyme
    MEF2C antikoerper, XMEF2C antikoerper, si:ch211-202e12.2 antikoerper, C5DELq14.3 antikoerper, DEL5q14.3 antikoerper, 5430401D19Rik antikoerper, 9930028G15Rik antikoerper, AV011172 antikoerper, Mef2 antikoerper, RGD1563119 antikoerper, id:ibd5026 antikoerper, mef2c antikoerper, wu:fc05b06 antikoerper, zgc:64184 antikoerper, zgc:85726 antikoerper, myocyte enhancer factor 2C antikoerper, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) antikoerper, myocyte enhancer factor 2cb antikoerper, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) L homeolog antikoerper, myocyte enhancer factor 2ca antikoerper, MEF2C antikoerper, mef2c antikoerper, mef2cb antikoerper, mef2c.L antikoerper, Mef2c antikoerper, mef2ca antikoerper
    Molekulargewicht
    '51 kDa
    Gen-ID
    4208
    UniProt
    Q06413
    Pathways
    Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
Sie sind hier:
Kundenservice